Monica Attia1, Shawn Kripalani1, Isha Darbari2, Robert Sheppard Nickel3. 1. The George Washington University School of Medicine and Health Sciences, Washington, DC. 2. University of Maryland School of Medicine, Baltimore, MD. 3. The George Washington University School of Medicine and Health Sciences, Washington, DC; Children's National Hospital, Division of Hematology, Washington, DC. Electronic address: rnickel@childrensnational.org.
Abstract
OBJECTIVE: To evaluate awareness of and attitudes toward preimplantation genetic testing (PGT) for sickle cell disease (SCD) among parents of children with SCD. STUDY DESIGN: Parents of children with SCD were given an educational handbook on PGT before a routine SCD clinic visit. After their clinic visit, parents were asked to complete an anonymous survey. RESULTS: Of 83 patents approached, 67 (81%) completed the survey. Only 16 of the 67 parents (24%) were previously aware of PGT for SCD. After our clinic-based education, 65 of the 67 parents (97%) indicated that it was important or very important for parents of children with SCD to know about PGT. Among parents interested in having more children, 29 of 32 (91%) would personally consider using PGT if covered by insurance. CONCLUSIONS: Parents of children with SCD are generally not aware of PGT. When educated in clinic, parents viewed information on PGT as valuable. Pediatricians and other health care professionals should inform parents of children with SCD about this reproductive option.
OBJECTIVE: To evaluate awareness of and attitudes toward preimplantation genetic testing (PGT) for sickle cell disease (SCD) among parents of children with SCD. STUDY DESIGN: Parents of children with SCD were given an educational handbook on PGT before a routine SCD clinic visit. After their clinic visit, parents were asked to complete an anonymous survey. RESULTS: Of 83 patents approached, 67 (81%) completed the survey. Only 16 of the 67 parents (24%) were previously aware of PGT for SCD. After our clinic-based education, 65 of the 67 parents (97%) indicated that it was important or very important for parents of children with SCD to know about PGT. Among parents interested in having more children, 29 of 32 (91%) would personally consider using PGT if covered by insurance. CONCLUSIONS: Parents of children with SCD are generally not aware of PGT. When educated in clinic, parents viewed information on PGT as valuable. Pediatricians and other health care professionals should inform parents of children with SCD about this reproductive option.
Authors: Isabel V Lake; Jake A Ruddy; James A Saba; Sajya M Singh; Macy L Early; Rachel J Strodel; Sophie Lanzkron; Jennifer W Mack; Emily R Meier; Mindy S Christianson; Lydia H Pecker Journal: J Assist Reprod Genet Date: 2021-11-22 Impact factor: 3.412
Authors: Robert Sheppard Nickel; Jacqueline Y Maher; Michael H Hsieh; Meghan F Davis; Matthew M Hsieh; Lydia H Pecker Journal: J Clin Med Date: 2022-04-21 Impact factor: 4.964
Authors: Fehmida Tehsin; Fatimah H Almutawah; Hawra K Almutawah; Maryam E Alwabari; Zahra M AlSultan; Hassan S Buawadh Journal: Cureus Date: 2021-12-14